Telix Pharmaceuticals Limited (TLX)

Last Closing Price: 7.52 (2026-03-06)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Telix Pharmaceuticals Limited (TLX) had Net Income of $-7.12M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$803.79M
Net Income
$-7.12M
$377.36M
$426.44M
$774.02M
$29.78M
$-35.04M
$-5.27M
$-5.27M
$-7.12M
$-7.12M
$-7.12M
$-7.12M
$29.78M
$51.19M
337.88M
337.88M
$-0.02
$-0.02
Balance Sheet Financials
$330.28M
$58.66M
$833.71M
$1.16B
$231.62M
$448.45M
$516.99M
$748.61M
$415.38M
$-177.45M
$415.38M
338.78M
Cash Flow Statement Financials
$-17.29M
$-285.92M
$-3.72M
$440.00M
$141.87M
$-298.13M
$19.35M
--
--
Fundamental Metrics & Ratios
1.43
--
--
0.52
1.12
53.05%
3.70%
3.70%
6.37%
-0.66%
-0.89%
$-42.98M
--
--
--
0.69
10.18
6.22
58.67
-1.72%
4.02%
-0.61%
-0.82%
$1.23
$-0.13
$-0.05